Trevi Therapeutics
TRVI
TRVI
20 hedge funds and large institutions have $45.9M invested in Trevi Therapeutics in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$230K | |
| 2 | +$6K | |
| 3 | +$5.7K | |
| 4 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2K |
Top Sellers
| 1 | -$377K | |
| 2 | -$359K | |
| 3 | -$228K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$35.6K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$25.1K |